hydroxyproline has been researched along with lisinopril in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Patel, VB; Preedy, VR; Richardson, PJ; Why, HJ | 1 |
| Ganjam, VK; Ramires, FJ; Sun, Y; Weber, KT; Zhou, G | 1 |
| Kandaswamy, V; Sen, S; Yang, CM; Young, D | 1 |
| Matsubara, BB; Matsubara, LS; Paiva, SA; Spadaro, J; Tornero, MT; Zornoff, LA | 1 |
| Itoh, M; Joh, T; Kuno, A; Masuda, K; Nakamura, S; Nakazawa, T; Nomura, T; Ogawa, K; Ohara, H; Shirai, T; Sogawa, M; Yamada, T | 1 |
| Ando, T; Itoh, M; Joh, T; Kuno, A; Masuda, K; Nakamura, S; Nomura, T; Ogawa, K; Ohara, H; Okamoto, T; Shirai, T; Tang, M; Yamada, T | 1 |
| Bulbuller, N; Ilhan, YS; Kirkil, C; Ozercan, R; Seckin, D | 1 |
| Aragon, FF; Cicogna, AC; Cordaro, FR; Gonçalves, G; Okoshi, K; Okoshi, MP; Padovani, CR; Ribeiro, HB; Zornoff, LA | 1 |
| Ghazi-Khansari, M; Mohammadi-Karakani, A; Sotoudeh, M | 1 |
| Abdallah, HM; El-Batran, SA; El-Demerdash, E; Salam, OM; Shaffie, NM | 1 |
| Aihara, M; Hattori, K; Hirano, T; Iwata, F; Muraguchi, M; Nakano, Y; Nishibayashi, S; Takiguchi, Y; Uehara, K; Yamada, Y | 1 |
11 other study(ies) available for hydroxyproline and lisinopril
| Article | Year |
|---|---|
Effects of angiotensin converting enzyme inhibition on cardiac collagen in hypertensive and normotensive rats.
Topics: Amlodipine; Animals; Blood Pressure; Collagen; Heart; Hydroxyproline; Hypertension; Lisinopril; Male; Myocardium; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1994 |
Fibrous tissue and angiotensin II.
Topics: Actins; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Collagen; Connective Tissue; Croton Oil; Fibroblasts; Granuloma; Hydroxyproline; Imidazoles; Lisinopril; Losartan; Macrophages; Male; Peptidyl-Dipeptidase A; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Wound Healing | 1997 |
Changes in collagen phenotypes during progression and regression of cardiac hypertrophy.
Topics: Aging; Angiotensin-Converting Enzyme Inhibitors; Animals; Blotting, Northern; Captopril; Cardiomegaly; Collagen; Heart Failure; Hydroxyproline; Lisinopril; Male; Myocardium; Rats; Rats, Inbred SHR; Rats, Inbred WKY; RNA | 1997 |
Effects of lisinopril on experimental ischemia in rats. Influence of infarct size.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomegaly; Fibrosis; Hydroxyproline; Lisinopril; Male; Myocardial Infarction; Rats; Rats, Wistar; Ventricular Remodeling | 1999 |
Angiotensin-converting enzyme inhibitor attenuates pancreatic inflammation and fibrosis in male Wistar Bonn/Kobori rats.
Topics: Actins; Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Chronic Disease; Fibrosis; Gene Expression; Hydroxyproline; Immunohistochemistry; Lisinopril; Male; Organ Size; Pancreas; Pancreatitis; Peptidyl-Dipeptidase A; Peroxidase; Rats; Rats, Wistar; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2003 |
Combination therapy with an angiotensin-converting enzyme inhibitor and an angiotensin II receptor blocker synergistically suppresses chronic pancreatitis in rats.
Topics: Actins; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Body Weight; Chronic Disease; Cytokines; Dose-Response Relationship, Drug; Drug Synergism; Fibrosis; Genes, ras; Hydroxyproline; Immunohistochemistry; Lisinopril; Male; Organ Size; Pancreatitis; Peptidyl-Dipeptidase A; Peroxidase; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; RNA, Messenger; Tetrazoles | 2005 |
The effect of an angiotensin converting enzyme inhibitor on intestinal wound healing.
Topics: Anastomosis, Surgical; Angiotensin-Converting Enzyme Inhibitors; Animals; Dose-Response Relationship, Drug; Hydroxyproline; Ileum; Lisinopril; Male; Models, Animal; Rats; Rats, Wistar; Tensile Strength; Transforming Growth Factor beta; Transforming Growth Factor beta1; Wound Healing | 2005 |
[Blockade of renin-angiotensin system attenuates cardiac remodeling in rats undergoing aortic stenosis].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Valve Stenosis; Echocardiography; Hydroxyproline; Hypertrophy, Left Ventricular; Lisinopril; Losartan; Male; Rats; Rats, Wistar; Ventricular Remodeling | 2005 |
Lisinopril ameliorates paraquat-induced lung fibrosis.
Topics: Animals; Hydroxyproline; Lipid Peroxidation; Lisinopril; Lung Diseases; Male; Paraquat; Rats; Rats, Wistar | 2006 |
Inhibition of the renin-angiotensin system attenuates the development of liver fibrosis and oxidative stress in rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Carbon Tetrachloride; Disease Models, Animal; Dose-Response Relationship, Drug; Fosinopril; Glutathione; Hydroxyproline; Lipid Peroxidation; Lisinopril; Liver; Liver Cirrhosis; Liver Function Tests; Losartan; Male; Oxidative Stress; Rats; Renin-Angiotensin System | 2008 |
Functional and structural changes in end-stage kidney disease due to glomerulonephritis induced by the recombinant alpha3(IV)NC1 domain.
Topics: Actins; Animals; Autoantigens; Collagen Type I; Collagen Type IV; Creatinine; Disease Models, Animal; Female; Gene Expression; Glomerulonephritis; Hydroxyproline; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Function Tests; Lisinopril; Mycophenolic Acid; Prednisolone; Rats; Rats, Inbred WKY; Recombinant Proteins; Transforming Growth Factor beta1 | 2010 |